{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:27:53Z","timestamp":1794436073431,"version":"4.9.1"},"reference-count":67,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023443","name":"Commercializations Promotion Agency for R&D Outcomes","doi-asserted-by":"publisher","award":["RS-2025-02310811"],"award-info":[{"award-number":["RS-2025-02310811"]}],"id":[{"id":"10.13039\/501100023443","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00409098"],"award-info":[{"award-number":["RS-2024-00409098"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2025-00513647"],"award-info":[{"award-number":["RS-2025-00513647"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.omtn.2026.102923","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T08:01:03Z","timestamp":1775030463000},"page":"102923","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["MASQ: A multiplex qPCR platform for quantitative alternative splicing analysis in clinical specimens"],"prefix":"10.1016","volume":"37","author":[{"given":"Hyejeong","family":"Jeong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namjoon","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Il","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heon Jong","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1088-3383","authenticated-orcid":false,"given":"Kee K.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2026.102923_bib1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev-biochem-060614-034316","article-title":"Mechanisms and Regulation of Alternative Pre-mRNA Splicing","volume":"84","author":"Lee","year":"2015","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.omtn.2026.102923_bib2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41580-020-0231-2","article-title":"Proteomic and interactomic insights into the molecular basis of cell functional diversity","volume":"21","author":"Bludau","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.omtn.2026.102923_bib3","doi-asserted-by":"crossref","first-page":"8390","DOI":"10.1073\/pnas.0507916103","article-title":"Alternative splicing in concert with protein intrinsic disorder enables increased functional diversity in multicellular organisms","volume":"103","author":"Romero","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.102923_bib4","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/ng.259","article-title":"Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing","volume":"40","author":"Pan","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2026.102923_bib5","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s12276-023-00981-7","article-title":"The implications of alternative pre-mRNA splicing in cell signal transduction","volume":"55","author":"Choi","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.omtn.2026.102923_bib6","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/nar\/gkm1054","article-title":"Alternative splicing and protein structure evolution","volume":"36","author":"Birzele","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102923_bib7","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.1073\/pnas.0700800104","article-title":"The implications of alternative splicing in the ENCODE protein complement","volume":"104","author":"Tress","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.102923_bib8","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3390\/genes13030401","article-title":"Alternative Splicing and Isoforms: From Mechanisms to Diseases","volume":"13","author":"Liu","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.omtn.2026.102923_bib9","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.15252\/embr.201541116","article-title":"The pathogenicity of splicing defects: mechanistic insights into pre-mRNA processing inform novel therapeutic approaches","volume":"16","author":"Daguenet","year":"2015","journal-title":"EMBO Rep."},{"key":"10.1016\/j.omtn.2026.102923_bib10","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s00439-017-1790-y","article-title":"Alternative splicing: the pledge, the turn, and the prestige : The key role of alternative splicing in human biological systems","volume":"136","author":"Gallego-Paez","year":"2017","journal-title":"Hum. Genet."},{"key":"10.1016\/j.omtn.2026.102923_bib11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12935-023-03094-3","article-title":"The role of alternative pre-mRNA splicing in cancer progression","volume":"23","author":"Choi","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.omtn.2026.102923_bib12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.4161\/rna.7.4.12744","article-title":"Pro-metastatic splicing of Ron proto-oncogene mRNA can be reversed: therapeutic potential of bifunctional oligonucleotides and indole derivatives","volume":"7","author":"Ghigna","year":"2010","journal-title":"RNA Biol."},{"key":"10.1016\/j.omtn.2026.102923_bib13","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1007\/s00018-011-0766-7","article-title":"Androgen receptor and its splice variants in prostate cancer","volume":"68","author":"Haile","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.omtn.2026.102923_bib14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10585-012-9514-0","article-title":"Alternatively spliced lysyl oxidase-like 4 isoforms have a pro-metastatic role in cancer","volume":"30","author":"Sebban","year":"2013","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.omtn.2026.102923_bib15","doi-asserted-by":"crossref","first-page":"R123","DOI":"10.1530\/ERC-22-0019","article-title":"Dysregulation of splicing variants and spliceosome components in breast cancer","volume":"29","author":"Gahete","year":"2022","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.omtn.2026.102923_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e14039","article-title":"A novel splicing variant of DJ-1 in Parkinson's disease induces mitochondrial dysfunction","volume":"9","author":"Cho","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.omtn.2026.102923_bib17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neuron.2006.09.017","article-title":"Splicing regulation in neurologic disease","volume":"52","author":"Licatalosi","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.omtn.2026.102923_bib18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neuron.2015.05.004","article-title":"Alternative Splicing in the Mammalian Nervous System: Recent Insights into Mechanisms and Functional Roles","volume":"87","author":"Raj","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.omtn.2026.102923_bib19","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/ana.22278","article-title":"Alternative splicing dysregulation secondary to skeletal muscle regeneration","volume":"69","author":"Orengo","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtn.2026.102923_bib20","doi-asserted-by":"crossref","first-page":"E620","DOI":"10.1073\/pnas.1715378115","article-title":"Dysregulation of cotranscriptional alternative splicing underlies CHARGE syndrome","volume":"115","author":"B\u00e9langer","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.102923_bib21","first-page":"14","article-title":"U2AF1 mutations alter splice site recognition in hematological malignancies","author":"Ilagan","year":"2014","journal-title":"bioRxiv"},{"key":"10.1016\/j.omtn.2026.102923_bib22","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1182\/blood.2019004260","article-title":"Splicing factor mutations in hematologic malignancies","volume":"138","author":"Chen","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.omtn.2026.102923_bib23","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1093\/nar\/gkx267","article-title":"A high quality Arabidopsis transcriptome for accurate transcript-level analysis of alternative splicing","volume":"45","author":"Zhang","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102923_bib24","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3727\/096368912X655154","article-title":"Aberrant Alternative Splicing Events in Parkinson's Disease","volume":"22","author":"Fu","year":"2013","journal-title":"Cell Transplant."},{"key":"10.1016\/j.omtn.2026.102923_bib25","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1093\/nar\/gkw533","article-title":"Splice-switching antisense oligonucleotides as therapeutic drugs","volume":"44","author":"Havens","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102923_bib26","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ijc.24052","article-title":"Modification of HER2 pre-mRNA alternative splicing and its effects on breast cancer cells","volume":"124","author":"Wan","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.omtn.2026.102923_bib27","doi-asserted-by":"crossref","first-page":"50031","DOI":"10.1074\/jbc.M308897200","article-title":"Reprogramming alternative pre-messenger RNA splicing through the use of protein-binding antisense oligonucleotides","volume":"278","author":"Villemaire","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omtn.2026.102923_bib28","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1214\/13-AOAS687","article-title":"Quantifying Alternative Splicing from Paired-End Rna-Sequencing Data","volume":"8","author":"Rossell","year":"2014","journal-title":"Ann. Appl. Stat."},{"key":"10.1016\/j.omtn.2026.102923_bib29","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1093\/bioinformatics\/btw076","article-title":"SplAdder: identification, quantification and testing of alternative splicing events from RNA-Seq data","volume":"32","author":"Kahles","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omtn.2026.102923_bib30","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/bib\/bbx034","article-title":"CASH: a constructing comprehensive splice site method for detecting alternative splicing events","volume":"19","author":"Wu","year":"2017","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.omtn.2026.102923_bib31","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1373\/49.3.425","article-title":"PCR-based Calibration Curves for Studies of Quantitative Gene Expression in Human Monocytes: Development and Evaluation","volume":"49","author":"\u00d8vsteb\u00f8","year":"2003","journal-title":"Clin. Chem."},{"key":"10.1016\/j.omtn.2026.102923_bib32","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2144\/96212rr01","article-title":"Quantitative RT-PCR: limits and accuracy","volume":"21","author":"Souaz\u00e9","year":"1996","journal-title":"Biotechniques"},{"key":"10.1016\/j.omtn.2026.102923_bib33","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.1038\/s44318-024-00262-7","article-title":"Alternative splicing of PBRM1 mediates resistance to PD-1 blockade therapy in renal cancer","volume":"43","author":"Cho","year":"2024","journal-title":"EMBO J."},{"key":"10.1016\/j.omtn.2026.102923_bib34","doi-asserted-by":"crossref","first-page":"8658","DOI":"10.1093\/nar\/gkac509","article-title":"RBFOX2-regulated TEAD1 alternative splicing plays a pivotal role in Hippo-YAP signaling","volume":"50","author":"Choi","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102923_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1364","article-title":"RNA-Seq methods for transcriptome analysis","volume":"8","author":"Hrdlickova","year":"2017","journal-title":"WIREs RNA"},{"key":"10.1016\/j.omtn.2026.102923_bib36","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1093\/nar\/gkab1129","article-title":"Accurate expression quantification from nanopore direct RNA sequencing with NanoCount","volume":"50","author":"Gleeson","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102923_bib37","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/tpj.13014","article-title":"Genomic limitations to RNA sequencing expression profiling","volume":"84","author":"Hirsch","year":"2015","journal-title":"Plant J."},{"key":"10.1016\/j.omtn.2026.102923_bib38","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1093\/bioinformatics\/btv488","article-title":"Benchmark analysis of algorithms for determining and quantifying full-length mRNA splice forms from RNA-seq data","volume":"31","author":"Hayer","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omtn.2026.102923_bib39","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1186\/1471-2105-13-S6-S11","article-title":"Challenges in estimating percent inclusion of alternatively spliced junctions from RNA-seq data","volume":"13","author":"Kakaradov","year":"2012","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.omtn.2026.102923_bib40","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41586-022-05035-y","article-title":"Transcriptome variation in human tissues revealed by long-read sequencing","volume":"608","author":"Glinos","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.102923_bib41","doi-asserted-by":"crossref","first-page":"E1291","DOI":"10.1073\/pnas.1403244111","article-title":"Cartography of neurexin alternative splicing mapped by single-molecule long-read mRNA sequencing","volume":"111","author":"Treutlein","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.102923_bib42","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s13059-021-02525-6","article-title":"Comprehensive characterization of single-cell full-length isoforms in human and mouse with long-read sequencing","volume":"22","author":"Tian","year":"2021","journal-title":"Genome Biol."},{"key":"10.1016\/j.omtn.2026.102923_bib43","doi-asserted-by":"crossref","first-page":"D124","DOI":"10.1093\/nar\/gkad745","article-title":"FLIBase: a comprehensive repository of full-length isoforms across human cancers and tissues","volume":"52","author":"Shi","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102923_bib44","article-title":"Finding the right fit: evaluation of short-read and long-read sequencing approaches to maximize the utility of clinical microbiome data","volume":"8","author":"Gehrig","year":"2022","journal-title":"Microb. Genom."},{"key":"10.1016\/j.omtn.2026.102923_bib45","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s41591-019-0457-8","article-title":"Identification of rare-disease genes using blood transcriptome sequencing and large control cohorts","volume":"25","author":"Fr\u00e9sard","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2026.102923_bib46","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1101\/gad.1941310","article-title":"Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model","volume":"24","author":"Hua","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.omtn.2026.102923_bib47","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/humu.10295","article-title":"Nonclassical splicing mutations in the coding and noncoding regions of the ATM Gene: maximum entropy estimates of splice junction strengths","volume":"23","author":"Eng","year":"2004","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omtn.2026.102923_bib48","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1086\/301948","article-title":"A point mutation in an intronic branch site results in aberrant splicing of COL5A1 and in Ehlers-Danlos syndrome type II in two British families","volume":"63","author":"Burrows","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2026.102923_bib49","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1086\/515472","article-title":"A rare branch-point mutation is associated with missplicing of fibrillin-2 in a large family with congenital contractural arachnodactyly","volume":"60","author":"Maslen","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2026.102923_bib50","article-title":"A Status Update of Modified Oligonucleotides for Chemotherapeutics Applications","volume":"Chapter 4","author":"Sanghvi","year":"2011","journal-title":"Curr. Protoc. Nucleic Acid Chem."},{"key":"10.1016\/j.omtn.2026.102923_bib51","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1093\/nar\/gkn342","article-title":"Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides","volume":"36","author":"Juliano","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102923_bib52","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/nat.2017.0665","article-title":"FDA Approval of Nusinersen for Spinal Muscular Atrophy Makes 2016 the Year of Splice Modulating Oligonucleotides","volume":"27","author":"Aartsma-Rus","year":"2017","journal-title":"Nucleic Acid Therapeut."},{"key":"10.1016\/j.omtn.2026.102923_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/tnsci-2017-0001","article-title":"ISS-N1 makes the first FDA-approved drug for spinal muscular atrophy","volume":"8","author":"Ottesen","year":"2017","journal-title":"Transl. Neurosci."},{"key":"10.1016\/j.omtn.2026.102923_bib54","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.2146\/news160063","article-title":"Eteplirsen approved for Duchenne muscular dystrophy","volume":"73","author":"Traynor","year":"2016","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.omtn.2026.102923_bib55","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1056\/NEJMoa1813279","article-title":"Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease","volume":"381","author":"Kim","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2026.102923_bib56","doi-asserted-by":"crossref","first-page":"16411","DOI":"10.1074\/jbc.M009256200","article-title":"Modification of alternative splicing of Bcl-x pre-mRNA in prostate and breast cancer cells. analysis of apoptosis and cell death","volume":"276","author":"Mercatante","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omtn.2026.102923_bib57","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1593\/neo.101744","article-title":"Identification of an exon 4-deletion variant of epidermal growth factor receptor with increased metastasis-promoting capacity","volume":"13","author":"Wang","year":"2011","journal-title":"Neoplasia"},{"key":"10.1016\/j.omtn.2026.102923_bib58","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4161\/bbug.2.3.15165","article-title":"Modulation of RNA splicing as a potential treatment for cancer","volume":"2","author":"Bauman","year":"2011","journal-title":"Bioeng. Bugs"},{"key":"10.1016\/j.omtn.2026.102923_bib59","first-page":"3","article-title":"Selection of fluorophore and quencher pairs for fluorescent nucleic acid hybridization probes","volume":"335","author":"Marras","year":"2006","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtn.2026.102923_bib60","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0378-4347(01)00337-1","article-title":"Quantitative determination of gene expression in human lymphocytes assessed by reverse transcription-polymerase chain reaction coupled to high-performance liquid chromatography","volume":"761","author":"And\u00ed","year":"2001","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.omtn.2026.102923_bib61","first-page":"671","article-title":"Basics of quantitative PCR 1: image analysis and quantitation of PCR products","volume":"41","author":"Sundfors","year":"1995","journal-title":"Cell. Mol. Biol."},{"key":"10.1016\/j.omtn.2026.102923_bib62","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1677\/jme.0.0290023","article-title":"Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems","volume":"29","author":"Bustin","year":"2002","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.omtn.2026.102923_bib63","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1525-1578(10)60013-X","article-title":"Reliable transcript quantification by real-time reverse transcriptase-polymerase chain reaction in primary neuroblastoma using normalization to averaged expression levels of the control genes HPRT1 and SDHA","volume":"7","author":"Fischer","year":"2005","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.omtn.2026.102923_bib64","doi-asserted-by":"crossref","first-page":"D1018","DOI":"10.1093\/nar\/gkv1288","article-title":"TCGASpliceSeq a compendium of alternative mRNA splicing in cancer","volume":"44","author":"Ryan","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102923_bib65","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1074\/jbc.M109721200","article-title":"Identification of Omi\/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction","volume":"277","author":"Hegde","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omtn.2026.102923_bib66","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1089\/humc.2015.2528","article-title":"A Phase I\/IIa Clinical Trial in Duchenne Muscular Dystrophy Using Systemically Delivered Morpholino Antisense Oligomer to Skip Exon 53 (SKIP-NMD)","volume":"26","year":"2015","journal-title":"Hum Gene Ther Clin Dev"},{"key":"10.1016\/j.omtn.2026.102923_bib67","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15824","article-title":"Genetic diagnosis of Mendelian disorders via RNA sequencing","volume":"8","author":"Kremer","year":"2017","journal-title":"Nat. Commun."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126000946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126000946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:35:58Z","timestamp":1794432958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253126000946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2162253126000946"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2026.102923","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MASQ: A multiplex qPCR platform for quantitative alternative splicing analysis in clinical specimens","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2026.102923","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102923"}}